MicroPort Scientific Corporation can trace its origin back to 1998 to a small office at ZJ Hi-Tech Park, Shanghai China where a group of dedicated individuals joined together with a common belief that advancements in medical technology could transform and enhance the patients' well-being not just in China but globally. During the past decades, the pioneers of MicroPort® have devoted themselves to this mission of advancing the forefront of technology innovation to develop the best and most affordable medical therapies to treat patients around the globe.
Through years of growth and innovation, MicroPort® has become a premier medical solution provider covering 10 major medical disciplines including interventional cardiology, orthopedics, interventional radiology, electrophysiology, diabetes and endocrine management, surgical management, and others. With over 165 products currently approved for use in over 5,000 hospitals worldwide, MicroPort® is contributing to a better world through its life-saving medical therapies and quality-improving care devices being used in patients every 18 seconds.
With a large global footprint of R&D and manufacturing facilities (Shanghai, Jiangsu, Zhejiang, Beijing, Shenzhen in China, and Memphis, TN in the United States), a strong focus on technology innovation with over 1,600 issued patents, and a global workforce of over 3,000 employees, MicroPort® is committed to its vision of being a patient oriented company capable of leading the future of minimally invasive healthcare and other emerging technologies.
